The new strains of coronavirus do not affect the ability of the antibodies created by the Moderna vaccine to neutralize the coronavirus, Tal Zax, a medical specialist, told JP Morgan Healthcare online conference.
According to the expert, the technology of messenger RNA, which is used in the vaccine, allows vaccination in the face of the emergence of new strains of coronavirus, against which the drug will also be effective.
Moderna published the first results of research on a vaccine against coronavirus in November. The interim results of the third phase of vaccine trials showed its effectiveness at the level of 94.5%.
*The article has been translated based on the content of Росбалт by www.rosbalt.ru. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!